Pharmacokinetics, tissue distribution and relative bioavailability of geniposide-solid lipid nanoparticles following oral administration

Abstract Geniposide has various pharmacological effects; however, low oral bioavailability limits its clinical utility. This study explores the pharmacokinetics, tissue distribution and relative bioavailability of geniposide-solid lipid nanoparticles (SLNs) following oral administration. The geniposide solution and geniposide-SLNs were orally administered to the rats, respectively. The Cmax value of geniposide in the geniposide-SLNs was significantly higher than that obtained with geniposide solution. Compared with the geniposide solution, the t1/2 and MRT were prolonged; the CL and V1/F were increased with geniposide-SLNs. The AUC0–∞values of geniposide-SLNs were 50 times greater than geniposide solution. The ratios of AUC0–8 h in the liver, spleen, heart, kidney, brain and lung of the geniposide-SLNs to geniposide solution were 25.93, 4.28, 27.91, 10.15, 5.16 and 16.22, respectively. Prepared geniposide-SLNs are very helpful for increasing the bioavailability of geniposide. These data suggest that SLNs are a promising delivery system to enhance the oral bioavailability of geniposide.

[1]  R. Bhandari,et al.  Pharmacokinetics, tissue distribution and relative bioavailability of isoniazid-solid lipid nanoparticles. , 2013, International journal of pharmaceutics.

[2]  Warren C W Chan,et al.  The effect of nanoparticle size, shape, and surface chemistry on biological systems. , 2012, Annual review of biomedical engineering.

[3]  Yanqing Sun,et al.  Pharmacokinetics of Geniposide in Zhi‐Zi‐Hou‐Pu Decoction and in Different Combinations of its Constituent Herbs , 2012, Phytotherapy research : PTR.

[4]  Xiaowei Yan,et al.  Simultaneous quantification of three iridoids in rat plasma after oral administration of Zhi-zi-chi decoction using LC-MS. , 2011, Journal of separation science.

[5]  T. Shimada,et al.  Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells. , 2011, Biological & pharmaceutical bulletin.

[6]  Shi-Ming Liu,et al.  Pharmacokinetics, tissue distribution and relative bioavailability of puerarin solid lipid nanoparticles following oral administration. , 2011, International journal of pharmaceutics.

[7]  Ying Liu,et al.  Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. , 2010, Biomaterials.

[8]  S. Chakraborty,et al.  Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: Zidovudine. , 2010, Chemical & pharmaceutical bulletin.

[9]  K. Bae,et al.  Effects of gardeniae fructus extract and geniposide on promoting ligament cell proliferation and collagen synthesis , 2010, Phytotherapy research : PTR.

[10]  K. Takayama,et al.  Effect of an experimental design for evaluating the nonlinear optimal formulation of theophylline tablets using a bootstrap resampling technique. , 2009, Chemical & pharmaceutical bulletin.

[11]  G. Zhai,et al.  Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. , 2009, International journal of pharmaceutics.

[12]  Wei Xu,et al.  Effect of geniposide, a hypoglycemic glucoside, on hepatic regulating enzymes in diabetic mice induced by a high-fat diet and streptozotocin , 2009, Acta Pharmacologica Sinica.

[13]  Jianhui Liu,et al.  Neuroprotection of geniposide against hydrogen peroxide induced PC12 cells injury: involvement of PI3 kinase signal pathway , 2009, Acta Pharmacologica Sinica.

[14]  S. Rossi,et al.  Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity. , 2008, International journal of pharmaceutics.

[15]  S. Bouchez,et al.  Genipin blues: an alternative non-toxic crosslinker for heart valves? , 2008, The Journal of heart valve disease.

[16]  P. Chao,et al.  Metabolism and pharmacokinetics of genipin and geniposide in rats. , 2008, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[17]  A. J. van der Ven,et al.  Antituberculosis drug‐induced hepatotoxicity: Concise up‐to‐date review , 2008, Journal of gastroenterology and hepatology.

[18]  D. Singh,et al.  Lipid carriers: a versatile delivery vehicle for proteins and peptides. , 2008, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan.

[19]  V. Bhardwaj,et al.  Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[20]  A. Mauro,et al.  Solid lipid nanoparticles: could they help to improve the efficacy of pharmacologic treatments for brain tumors? , 2007, Neurological research.

[21]  E. Park,et al.  Anti-inflammatory evaluation of gardenia extract, geniposide and genipin. , 2006, Journal of ethnopharmacology.

[22]  J. Lai,et al.  Immunosuppressive iridoids from the fruits of Gardenia jasminoides. , 2005, Journal of natural products.

[23]  C. Barry,et al.  Prospects for new antitubercular drugs. , 2004, Current opinion in microbiology.

[24]  T. Tsai,et al.  Measurement of unbound geniposide in blood, liver, brain and bile of anesthetized rats: an application of pharmacokinetic study and its influence on acupuncture , 2004 .

[25]  C. Lim,et al.  Geniposide, an anti-angiogenic compound from the fruits of Gardenia jasminoides. , 2004, Planta medica.

[26]  A. Florence.  Issues in Oral Nanoparticle Drug Carrier Uptake and Targeting , 2004, Journal of drug targeting.

[27]  S. Garg,et al.  Bioadhesive microspheres as a controlled drug delivery system. , 2003, International journal of pharmaceutics.

[28]  Giovanni Luca,et al.  Production of lipospheres as carriers for bioactive compounds. , 2002, Biomaterials.

[29]  J. Liaw,et al.  Effect of in vitro and in vivo aerosolized treatment with geniposide on tracheal permeability in ovalbumin-induced guinea pigs. , 2001, European journal of pharmacology.

[30]  Y. Ikeda,et al.  Antithrombotic Effect of Geniposide and Genipin in the Mouse Thrombosis Model , 2001, Planta medica.

[31]  Y. Takeda,et al.  Simultaneous Estimation of Geniposide and Genipin in Mouse Plasma Using High-Performance Liquid Chromatography , 2001, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[32]  R. Cavalli,et al.  Non-stealth and stealth solid lipid nanoparticles (SLN) carrying doxorubicin: pharmacokinetics and tissue distribution after i.v. administration to rats. , 2000, Pharmacological research.

[33]  R. Müller,et al.  Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[34]  H. Bunjes,et al.  Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential , 1997 .

[35]  J. J. Yang,et al.  Comparisons of geniposidic acid and geniposide on antitumor and radioprotection after sublethal irradiation. , 1997, Cancer letters.

[36]  R. Müller,et al.  Solid lipid nanoparticles (SLN) for controlled drug delivery , 1996 .

[37]  A. Fahlvik,et al.  Adsorption of poly(sodium(4)styrenesulfonate) on colloidal iron oxide particles , 1996 .

[38]  R. Müller,et al.  Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization , 1994 .

[39]  S. Koch.  Pharmacology And Applications Of Chinese Materia Medica , 2016 .

[40]  C. DindaSubas,et al.  FORMULATION AND EVALUATION OF SOLID LIPID NANOPARTICLES OF A POORLY WA TER SOLUBLE MODEL DRUG, IBUPROFEN , 2012 .

[41]  Xinsheng Peng,et al.  Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design , 2011 .

[42]  R. Müller,et al.  Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes. , 2010, Handbook of experimental pharmacology.

[43]  S. Manikiran,et al.  SOLID LIPID NANOPARTICLES: COLLOIDAL CARRIER SYSTEMS FOR DRUG DELIVERY , 2010 .

[44]  Jongseo Lee,et al.  Geniposide from Gardenia jasminoides attenuates neuronal cell death in oxygen and glucose deprivation-exposed rat hippocampal slice culture. , 2006, Biological & pharmaceutical bulletin.